| 产品详情 |
| Edit |   |
| Product Name | p14ARF/CDKN2A Knockout HeLa Cell Lysate |
| Description | The p14ARF/CDKN2A Knockout HeLa Cell Lysate from Novus Biologicals is derived from human. It has been validated for the following applications: Western Blot. |
| Size | 2 vials |
| Concentration | lyophilized |
| Applications | Western Blot |
| Other Names | ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, p16, p16-INK4, p16INK4a, p16-INK4a, P19, p19ARF, TP16 |
| Gene, Accession, CAS # | CDKN2A, Gene ID: 1029 |
| Catalog # | NBP2-66410 |
| Price | |
| Order / More Info | p14ARF/CDKN2A Knockout HeLa Cell Lysate from NOVUS BIOLOGICALS, LLC |
| Product Specific References | n/a |
| 产品资料 |
|
|